In vivo molecular imaging of cardiac angiogenesis in persons with and without type 2 diabetes: A cross-sectional 68Ga-RGD-PET study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
In vivo molecular imaging of cardiac angiogenesis in persons with and without type 2 diabetes : A cross-sectional 68Ga-RGD-PET study. / Laursen, Jens Christian; Rasmussen, Ida Kirstine Bull; Zobel, Emilie Hein; Hasbak, Philip; Holmvang, Lene; Hansen, Christian Stevns; von Scholten, Bernt Johan; Frimodt-Moller, Marie; Rossing, Peter; Hansen, Tine Willum; Kjaer, Andreas; Ripa, Rasmus Sejersten.
In: Diabetic Medicine, Vol. 40, No. 1, 2023, p. e14960.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - In vivo molecular imaging of cardiac angiogenesis in persons with and without type 2 diabetes
T2 - A cross-sectional 68Ga-RGD-PET study
AU - Laursen, Jens Christian
AU - Rasmussen, Ida Kirstine Bull
AU - Zobel, Emilie Hein
AU - Hasbak, Philip
AU - Holmvang, Lene
AU - Hansen, Christian Stevns
AU - von Scholten, Bernt Johan
AU - Frimodt-Moller, Marie
AU - Rossing, Peter
AU - Hansen, Tine Willum
AU - Kjaer, Andreas
AU - Ripa, Rasmus Sejersten
PY - 2023
Y1 - 2023
N2 - Aims To assess cardiac angiogenesis in type 2 diabetes by positron emission tomography (PET) tracer [Ga-68]Ga-NODAGA-E[(cRGDyK)](2) (Ga-68-RGD) imaging. Methods Cross-sectional study including 20 persons with type 2 diabetes and 10 non-diabetic controls (CONs). Primary prespecified outcome was difference in cardiac angiogenesis (cardiac Ga-68-RGD mean target-to-background ratio [TBRmean]) between type 2 diabetes and CONs. Secondary outcome was to investigate associations between cardiac angiogenesis and kidney function and other risk factors. Results Participants with type 2 diabetes had a mean +/- SD age of 61 +/- 9 years, 30% were women, median (IQR) diabetes duration of 11 (6-19) years and 3 (15%) had a history of cardiovascular disease. The CONs had comparable age and sex distribution to the participants with type 2 diabetes, and none had a history of coronary artery disease. Myocardial flow reserve was lower in type 2 diabetes (2.7 +/- 0.6) compared with CONs (3.4 +/- 1.2) ( p = 0.03) and coronary artery calcium score was higher (562 [142-905] vs. 1 [0-150] p = 0.04). Cardiac Ga-68-RGD TBRmean was similar in participants with type 2 diabetes (0.89 +/- 0.09) and CONs (0.89 +/- 0.10) ( p = 0.92). Cardiac Ga-68-RGD TBRmean was not associated with estimated glomerular filtration rate, urine albumin creatinine ratio, cardiovascular disease, coronary artery calcium score or baroreflex sensitivity, neither in pooled analyses nor in type 2 diabetes. Conclusions Cardiac angiogenesis, evaluated with Ga-68-RGD PET, was similar in type 2 diabetes and CONs. Cardiac angiogenesis was not associated with kidney function or other risk markers in pooled analyses or in analyses restricted to type 2 diabetes.
AB - Aims To assess cardiac angiogenesis in type 2 diabetes by positron emission tomography (PET) tracer [Ga-68]Ga-NODAGA-E[(cRGDyK)](2) (Ga-68-RGD) imaging. Methods Cross-sectional study including 20 persons with type 2 diabetes and 10 non-diabetic controls (CONs). Primary prespecified outcome was difference in cardiac angiogenesis (cardiac Ga-68-RGD mean target-to-background ratio [TBRmean]) between type 2 diabetes and CONs. Secondary outcome was to investigate associations between cardiac angiogenesis and kidney function and other risk factors. Results Participants with type 2 diabetes had a mean +/- SD age of 61 +/- 9 years, 30% were women, median (IQR) diabetes duration of 11 (6-19) years and 3 (15%) had a history of cardiovascular disease. The CONs had comparable age and sex distribution to the participants with type 2 diabetes, and none had a history of coronary artery disease. Myocardial flow reserve was lower in type 2 diabetes (2.7 +/- 0.6) compared with CONs (3.4 +/- 1.2) ( p = 0.03) and coronary artery calcium score was higher (562 [142-905] vs. 1 [0-150] p = 0.04). Cardiac Ga-68-RGD TBRmean was similar in participants with type 2 diabetes (0.89 +/- 0.09) and CONs (0.89 +/- 0.10) ( p = 0.92). Cardiac Ga-68-RGD TBRmean was not associated with estimated glomerular filtration rate, urine albumin creatinine ratio, cardiovascular disease, coronary artery calcium score or baroreflex sensitivity, neither in pooled analyses nor in type 2 diabetes. Conclusions Cardiac angiogenesis, evaluated with Ga-68-RGD PET, was similar in type 2 diabetes and CONs. Cardiac angiogenesis was not associated with kidney function or other risk markers in pooled analyses or in analyses restricted to type 2 diabetes.
KW - atherosclerosis
KW - autonomic neuropathy
KW - imaging
KW - kidney disease
KW - Type 2 diabetes
KW - POSITRON-EMISSION-TOMOGRAPHY
KW - INTEGRIN
KW - QUANTIFICATION
KW - EXPRESSION
KW - DIAGNOSIS
KW - MELLITUS
KW - DISEASE
KW - IMPACT
U2 - 10.1111/dme.14960
DO - 10.1111/dme.14960
M3 - Journal article
C2 - 36135822
VL - 40
SP - e14960
JO - Diabetic Medicine
JF - Diabetic Medicine
SN - 0742-3071
IS - 1
ER -
ID: 323205957